ENTITY
InnoCare Pharma

InnoCare Pharma (9969 HK)

107
Analysis
Health Care • China
InnoCare Pharma is a commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing drugs for cancer and autoimmune diseases. Its pipeline includes key products like orelabrutinib, tafasitamab, and ICP-332. The company was co-founded in 2015 and is headquartered in Beijing, China.
more
Company Event • 19 Aug 2026 16:00 • Upcoming
Add To Calendar
Company Event • 23 Apr 2026 18:45 • Upcoming
Add To Calendar
Company Event • 25 Mar 2026 20:30 • Latest
Company Event • 14 Nov 2025 10:00 • Upcoming
Add To Calendar
Company Event • 09 Oct 2025 08:30 • Upcoming
Add To Calendar
x